Sunday, August 30, 2026

Boeing Stock Over 6% Up So Far On Thursday

ViaNews Editorial Team

December 3, 2020

Boeing Stock Over 6% Up So Far On Thursday
Shares of Boeing rose 6.21% to $237.76 at 14:22 EST on Thursday, after two sequential sessions in a row of gains. The New York Stock Exchange is rising 0.46% to $14,254.00, after two consecutive sessions in a row of gains, on what at the moment seems, a somewhat positive trend exchanging session today. Boeing's last close was $223.85, 49.06% under its 52-week high of $354.40.

News about Boeing today

Boeing wins first big 737 MAX order since grounding ended. According to today's article on The Wall Street Journal, "Ryanair Holdings PLC on Thursday said it agreed to buy 75 of Boeing 737 MAX jets, a boost for the troubled plane maker following the aircraft's prolonged grounding."

Boeing's Sales

Boeing's sales growth is a negative 8.2% for the present quarter and 0.9% for the next. The company's growth estimates for the ongoing quarter and the next is 58.4% and 75.3%, respectively.

Boeing's Revenue

Year-on-year quarterly revenue growth declined by 29.2%, now sitting on 60.76B for the twelve trailing months.

Boeing's Stock Top and Bottom Yearly Value

Boeing's stock is valued at $237.76 at 14:22 EST, way under its 52-week high of $354.40 and way higher than its 52-week low of $89.00.

Boeing's Moving Average

Boeing's value is way above its 50-day moving average of $180.05 and way higher than its 200-day moving average of $173.27.
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com